Risperidone and Paliperone in the Treatment of Psychosis
Author:
- 5 November 2022
- book chapter
- Published by Springer Nature
- p. 1769-1782
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic ReviewPediatrics, 2012
- Paliperidone Extended ReleaseDrugs, 2010
- The Pharmacokinetics of Paliperidone Versus RisperidonePsychosomatics, 2010
- Paliperidone for schizophreniaAmerican Journal of Health-System Pharmacy, 2008
- Risperidone for autism spectrum disorderCochrane Database of Systematic Reviews, 2007
- Risperidone: a reviewExpert Opinion on Pharmacotherapy, 2005
- Safety and Efficacy of Long-Acting Risperidone in SchizophreniaThe Journal of Clinical Psychiatry, 2004
- Longitudinal Comparative Study of Risperidone and Conventional Neuroleptics for Treating Patients With SchizophreniaJournal of Clinical Psychopharmacology, 2000
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiographyBrain Research, 1993